Search results
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares
ETF DAILY NEWS· 2 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. Following ...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 5 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 24 hours agoProofPilot, the industry's premier platform for patient & site automation, guidance, and seamless execution, announces today its double victory alongside esteemed partner Moderna< ...
Moderna to Present at Upcoming Conferences in May/June 2024
The Sacramento Bee· 2 days agoModerna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 4 days agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks· 2 days agoFree Report) is one of the stocks most watched by Zacks.com visitors lately. Over the past month, shares of this biotechnology company have returned +11.6%, compared to the Zacks S&P 500 composite's ...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 4 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 3 days agoWealthspire Advisors LLC trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.9% in the fourth quarter, according to its most recent disclosure with the Securities ...
Benjamin F. Edwards & Company Inc. Raises Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 4 days agoBenjamin F. Edwards & Company Inc. raised its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 17.2% during the 4th quarter, according to its most recent filing ...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 5 days agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...